SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW 9-N-ALKYL DERIVATIVES OF 9(S)-ERYTHROMYCYLAMINE

被引:16
作者
KIRST, HA
WIND, JA
LEEDS, JP
WILLARD, KE
DEBONO, M
BONJOUKLIAN, R
GREENE, JM
SULLIVAN, KA
PASCHAL, JW
DEETER, JB
JONES, ND
OTT, JL
FELTYDUCKWORTH, AM
COUNTER, FT
机构
[1] Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis
关键词
D O I
10.1021/jm00173a028
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 9-iV-alkyl derivatives of 9(S)-erythromycylamine has been synthesized by reductive alkylation of erythromycylamine with aliphatic aldehydes and sodium cyanoborohydride. Alternative syntheses employing hydrogenation methods have also been developed. These new 9-N-alkyl derivatives possess excellent antimicrobial activity in vitro and in vivo, especially when administered orally to treat experimental infections in mice. From structure-activity studies, 9-N-(l-propyl)erythromycylamine (LY281389) was selected as the most efficacious derivative. These methods have also been extended to the synthesis of some 9-N,N-dialkyl derivatives of erythromycylamine. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:3086 / 3094
页数:9
相关论文
共 21 条
[21]  
WOITUN E, 1981, Patent No. 4256736